Neu Base Therapeutics Inc (NBSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBSE | AZN | AMGN | GILD | BMY |
| Company | Neu Base Therapeutics Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 0.3810 | 196.72 | 376.17 | 147.73 | 60.60 |
| High | 0.3914 | 197.43 | 377.62 | 148.69 | 60.60 |
| Low | 0.3650 | 195.97 | 372.74 | 146.84 | 59.98 |
| Latest | 0.3780 | 197.38 | 375.43 | 148.45 | 60.30 |
| Change | -0.0125 | +2.43 | -1.54 | +1.82 | -0.33 |
| % Change | -3.20% | +1.25% | -0.41% | +1.24% | -0.54% |
| Volume | 97,700 | 284,929 | 293,527 | 579,249 | 909,988 |
| 20-Day Average Volume | 89,365 | 2,136,253 | 2,559,998 | 7,121,303 | 12,302,700 |
| Previous Close | 0.3905 | 194.95 | 376.97 | 146.63 | 60.63 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.4150 | 202.96 | 375.67 | 149.34 | 60.89 |
| 20-Day Raw Stochastic | 17.09% | 30.61% | 40.18% | 31.73% | 27.90% |
| 20-Day Relative Strength | 33.52 | 50.45 | 54.89 | 55.38 | 55.45 |
| Weighted Alpha | -76.26 | +32.56 | +27.17 | +39.41 | +14.60 |
| Today's Opinion | 100% Sell | 80% Buy | 88% Buy | 88% Buy | 88% Buy |
| Previous Opinion | 100% Sell | 80% Buy | 100% Buy | 88% Buy | 88% Buy |
| Last Month's Opinion | 88% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.67% since 05/03/24 | -2.61% since 03/03/26 | -1.02% since 03/03/26 | -0.31% since 03/03/26 | -1.58% since 03/03/26 |
| Low | 0.3600 on 05/06/24 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 59.25 on 03/09/26 |
| High | 0.4299 on 05/07/24 | 203.29 on 03/04/26 | 380.09 on 03/04/26 | 148.92 on 03/04/26 | 62.58 on 03/04/26 |
| 1-Month | |||||
| %Chg | -5.78% since 04/10/24 | +1.60% since 02/10/26 | +2.34% since 02/10/26 | +0.10% since 02/10/26 | -1.00% since 02/10/26 |
| Low | 0.3600 on 05/06/24 | 189.35 on 03/09/26 | 361.00 on 02/11/26 | 142.77 on 03/06/26 | 59.23 on 02/19/26 |
| High | 0.4653 on 04/15/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 3-Month | |||||
| %Chg | -44.41% since 02/09/24 | +7.37% since 12/10/25 | +18.32% since 12/10/25 | +21.46% since 12/10/25 | +17.65% since 12/10/25 |
| Low | 0.3600 on 05/06/24 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 50.44 on 12/11/25 |
| High | 1.1500 on 03/20/24 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | -43.95% since 11/10/23 | +21.58% since 09/10/25 | +33.99% since 09/10/25 | +27.88% since 09/10/25 | +27.78% since 09/10/25 |
| Low | 0.3600 on 05/06/24 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 1.5100 on 11/30/23 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,418 | 302,349,504 | 203,212,464 | 182,029,584 | 123,471,424 |
| Shares Outstanding, K | 3,752 | 1,550,908 | 539,068 | 1,241,421 | 2,036,474 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -4,370,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -1,820,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 0.81 | 0.32 | 0.45 | 0.36 | 0.26 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.95 on 11/09/23 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 01/01/70 | 05/05/26 | 05/07/26 | 04/23/26 | 04/23/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.20 | 16.91 | 17.66 | 9.80 |